CoChat

Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study

Open access
Yubero-Serrano, Elena Maria, Delgado-Lista, Javier, Peña-Orihuela, Patricia, Perez-Martinez, Pablo, Fuentes, Francisco, Marin, Carmen, Tunez, Isaac, Jose Tinahones, Francisco, Perez-Jimenez, Francisco, Roche, Helen M, Lopez-Miranda, Jose · 2013 · Experimental & Molecular Medicine
Cited by 96

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Previous evidence supports the important role that oxidative stress (OxS) plays in metabolic syndrome (MetS)-related manifestations. We determined the relationship between the number of MetS components and the degree of OxS in MetS patients. In this comparative cross-sectional study from the LIPGENE cohort, a total of 91 MetS patients (43 men and 48 women; aged between 45 and 68 years) were divided into four groups based on the number of MetS components: subjects with 2, 3, 4 and 5 MetS components (n=20, 31, 28 and 12, respectively). We measured ischemic reactive hyperemia (IRH), plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), total nitrite, lipid peroxidation products (LPO), hydrogen peroxide (H2O2), superoxide dismutase (SOD) and glutathione peroxidase (GPx) plasma activities. sVCAM-1, H2O2 and LPO levels were lower in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. IRH and total nitrite levels were higher in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. SOD and GPx activities were lower in subjects with 2 MetS components than subjects with 4 or 5 MetS components. Waist circumference, weight, age, homeostatic model assessment-β, triglycerides (TGs), high-density lipoprotein and sVCAM-1 levels were significantly correlated with SOD activity. MetS subjects with more MetS components may have a higher OxS level. Furthermore, association between SOD activity and MetS components may indicate that this variable could be the most relevant OxS biomarker in patients suffering from MetS and could be used as a predictive tool to determine the degree of the underlying OxS in MetS. An exploration of the disruptions associated with metabolic syndrome yields potentially useful indicators for assessing physiological damage. Metabolic syndrome encompasses different combinations of symptoms, including obesity and elevated cholesterol levels, but it is generally associated with risk of diabetes, cardiovascular disease and kidney disease. Research has also associated metabolic syndrome with cellular damage from a process called oxidative stress. Jose Lopez-Miranda's team at Spain's University of Cordoba examined these manifestations in a cohort of patients. They grouped their subjects based on their number of metabolic syndrome symptoms, and observed that patients with severe disease produced the greatest amount of molecules that cause oxidative stress. These patients also produced higher levels of superoxide dismutase, an enzyme that clears those molecules, revealing a potentially useful biomarker for tracking oxidative stress and examining its effects in metabolic syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2013.53

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 96

Metadata

Authors
Yubero-Serrano, E. M., Delgado-Lista, J., Peña-Orihuela, P., Perez-Martinez, P., Fuentes, F., Marin, C., Tunez, I., Jose Tinahones, F., Perez-Jimenez, F., Roche, H. M., & Lopez-Miranda, J.
Venue
Experimental & Molecular Medicine
Published
2013-06-21
Volume
45
Issue
6
Pages
e28-e28
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2011534124
Cited by
96
References
9
FWCI
7.76
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.